Eli Lilly and Company operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other
companies in this sector in the United States:
sales of $22.09 billion
Bristol-Myers Squibb Company
Eli Lilly and Company reported sales of $24.56 billion
December of 2018.
increase of 7.4%
versus 2017, when the company's sales were $22.87 billion.
This was the fourth straight year of sales growth at Eli Lilly and Company.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Eli Lilly and Company had sales
of $23.11 billion.